EC Dairy - Meat Food Safety Project Strengthens Biacore's Opportunities in The Food Analysis Market

Biacore Announces Final Results of FoodSENSE Demonstration Project



Apr 23, 2001, 01:00 ET from Biacore International AB

    UPPSALA, Sweden, April 23 /PRNewswire/ --
 Biacore International AB (Biacore) (Nasdaq:   BCOR) (SSE: BCOR) today announced
 that an important EC food safety improvement project, FoodSENSE, has
 successfully demonstrated the applicability of Biacore's SPR (Surface Plasmon
 Resonance) based biosensor technology for the analysis of veterinary drug
 residues in foods such as milk and meat.  Final results from the project have
 shown that substantially higher daily throughput of tests can be performed
 using SPR technology, with the capacity to detect a much wider range of
 residues compared to existing test methods.
     The FoodSENSE project, supported by the EC Programme For Agriculture And
 Fisheries (EC FAIR), started in mid 1998 and involved eight other
 organisations from four countries.  The project's aim was to determine the
 applicability of using optical biosensors for screening analysis of veterinary
 drug residues in food.  To ensure that the public is protected against
 potentially harmful veterinary residues, such as hormones and antibiotics,
 government and private sector surveillance schemes operate to monitor and
 control the European food production industry.  Although there is an extensive
 range of tests available, few techniques have satisfactory throughput,
 sensitivity or reliability.
     During the project, Biacore developed a new SPR-based biosensor prototype,
 with increased analysis capacity of one 96-well microplate in 30 minutes
 (equivalent to over 1,500 analyses per day).  The cutting-edge technology
 proved to be suitable for use in such challenging environments as abattoirs
 and dairies and was tested in a variety of field situations on meat and dairy
 products, with results being compared to existing methods.  The high
 throughput system was shown to achieve automated, multi-analyses on a range of
 important drug residues.
     Commenting on the successful conclusion to the project, Dr. Karl-Erik
 Hellenaes, FoodSENSE Coordinator and Senior Chemist at the Swedish National
 Food Administration, said "Completing the FoodSENSE project with such positive
 results is extremely encouraging.  During the two and a half-year project we
 have been able to validate the technology in a number of very challenging food
 production sites and National Reference laboratories.  We have shown that
 Biacore's SPR technology really improves both the reliable detection of
 veterinary residues and the capability of food production laboratories to
 assure the safety, quality and composition of food."
     "It is clear that the prototype delivered enormously high throughput of
 testing in both laboratory and industrial environments," commented Esa
 Stenberg, Head of Business Unit Food, Biacore.  "As an example more than 20%
 of all carcasses in a meat factory were tested for certain antibiotic residues
 each day.  This compares with less than 0.1% level of testing currently
 performed at that factory."
     Adding that: "The success of the prototype system in the FoodSENSE project
 expands the future potential of Biacore's SPR technology within food
 production, for analysing large numbers of food samples for residual
 contaminants."
     The FoodSENSE project also involved a team of researchers from Queen's
 University in Belfast, responsible for development and production of new SPR
 assay kits. "The high sample throughput of the prototype biosensor put great
 demands on the assay kits that had to be constructed for the project.
 Pre-coated chips were successfully developed to run up to three different
 analytes in one experiment", said Dr Chris Elliott, Principal Investigator at
 Queens University.
     As a result of the FoodSENSE project a new company, XenoSense Limited, has
 been formed, with the focus of implementing the scientific and technological
 advances made during FoodSENSE.  As issues concerning food safety coupled to
 reliable means of measurement are foremost in the thinking of many it is hoped
 that XenoSense in partnership with Biacore will exploit the many opportunities
 available for fast and accurate food analysis.
     Biacore expects their products to be of particular use to National
 Reference laboratories, food producers and those involved in the food supply
 industry.  The FoodSENSE project results are also of importance to policy
 makers and consumer organisations interested in the areas of public health and
 food safety.
 
     This press release contains certain forward-looking statements within the
 meaning of the United States Private Securities Litigation Reform Act of 1995,
 which, by their nature, involve risk and uncertainty because they relate to
 events and depend on circumstances that will occur in the future.  There are a
 number of factors that could cause actual results and developments to differ
 materially from those expressed or implied by these forward-looking
 statements.
 
     Notes:
     XenoSense Ltd was formed in October 2000, as a spin-off from Biacore's
 Food Business Unit and develops and manufactures assay kits and reagents for
 the analysis of food contaminants, such as veterinary medicine residues,
 toxins and bacteria, using Biacore's SPR technology.  Based in Belfast,
 Northern Ireland, the Company received initial funding from Biacore along with
 the University Challenge Fund, which is owned by Queens University, the
 University of Ulster and other private investors.  XenoSense has the right to
 commercialize products and certain areas of research carried out by the
 Department of Agriculture and Rural Development (DARD) in Northern Ireland.
     Biacore is a global market leader in Surface Plasmon Resonance (SPR) based
 technology with its own sales operations in the U.S., across Europe, in Japan,
 Australia and New Zealand.  The technology is protected by a strong patent
 portfolio.  Target groups consist primarily of medical and life science
 research laboratories and pharmaceutical and biotechnology companies all over
 the world.  Biacore focuses on drug discovery as the prime area for future
 growth.  The company currently has six systems on the market with its
 BIACORE(R)3000 system offering specific application in drug discovery
 processes upstream of high-throughput screening (HTS).  A new high-performance
 is currently under late-stage development and will focus on applications
 downstream of HTS.
     Based in Uppsala, Sweden, the company is listed on the OM Stockholm
 Exchange and Nasdaq in the U.S.  In 1999 the company has sales of SEK
 340.4 million and an operating income of SEK 67.6 million.
 
     Further information on Biacore can be found on the web: www.biacore.com .
 
     Address and phone:  Biacore International AB
                         Rapsgatan 7, SE-754 50 Uppsala, SWEDEN
                         Phone: +46 (0)18-675700
                         Fax: +46 (0)18-150111info@biacore.com
 
     More information on the FoodSENSE project can be found at
 http://www.slv.se/foodsense .
 
 

SOURCE Biacore International AB
    UPPSALA, Sweden, April 23 /PRNewswire/ --
 Biacore International AB (Biacore) (Nasdaq:   BCOR) (SSE: BCOR) today announced
 that an important EC food safety improvement project, FoodSENSE, has
 successfully demonstrated the applicability of Biacore's SPR (Surface Plasmon
 Resonance) based biosensor technology for the analysis of veterinary drug
 residues in foods such as milk and meat.  Final results from the project have
 shown that substantially higher daily throughput of tests can be performed
 using SPR technology, with the capacity to detect a much wider range of
 residues compared to existing test methods.
     The FoodSENSE project, supported by the EC Programme For Agriculture And
 Fisheries (EC FAIR), started in mid 1998 and involved eight other
 organisations from four countries.  The project's aim was to determine the
 applicability of using optical biosensors for screening analysis of veterinary
 drug residues in food.  To ensure that the public is protected against
 potentially harmful veterinary residues, such as hormones and antibiotics,
 government and private sector surveillance schemes operate to monitor and
 control the European food production industry.  Although there is an extensive
 range of tests available, few techniques have satisfactory throughput,
 sensitivity or reliability.
     During the project, Biacore developed a new SPR-based biosensor prototype,
 with increased analysis capacity of one 96-well microplate in 30 minutes
 (equivalent to over 1,500 analyses per day).  The cutting-edge technology
 proved to be suitable for use in such challenging environments as abattoirs
 and dairies and was tested in a variety of field situations on meat and dairy
 products, with results being compared to existing methods.  The high
 throughput system was shown to achieve automated, multi-analyses on a range of
 important drug residues.
     Commenting on the successful conclusion to the project, Dr. Karl-Erik
 Hellenaes, FoodSENSE Coordinator and Senior Chemist at the Swedish National
 Food Administration, said "Completing the FoodSENSE project with such positive
 results is extremely encouraging.  During the two and a half-year project we
 have been able to validate the technology in a number of very challenging food
 production sites and National Reference laboratories.  We have shown that
 Biacore's SPR technology really improves both the reliable detection of
 veterinary residues and the capability of food production laboratories to
 assure the safety, quality and composition of food."
     "It is clear that the prototype delivered enormously high throughput of
 testing in both laboratory and industrial environments," commented Esa
 Stenberg, Head of Business Unit Food, Biacore.  "As an example more than 20%
 of all carcasses in a meat factory were tested for certain antibiotic residues
 each day.  This compares with less than 0.1% level of testing currently
 performed at that factory."
     Adding that: "The success of the prototype system in the FoodSENSE project
 expands the future potential of Biacore's SPR technology within food
 production, for analysing large numbers of food samples for residual
 contaminants."
     The FoodSENSE project also involved a team of researchers from Queen's
 University in Belfast, responsible for development and production of new SPR
 assay kits. "The high sample throughput of the prototype biosensor put great
 demands on the assay kits that had to be constructed for the project.
 Pre-coated chips were successfully developed to run up to three different
 analytes in one experiment", said Dr Chris Elliott, Principal Investigator at
 Queens University.
     As a result of the FoodSENSE project a new company, XenoSense Limited, has
 been formed, with the focus of implementing the scientific and technological
 advances made during FoodSENSE.  As issues concerning food safety coupled to
 reliable means of measurement are foremost in the thinking of many it is hoped
 that XenoSense in partnership with Biacore will exploit the many opportunities
 available for fast and accurate food analysis.
     Biacore expects their products to be of particular use to National
 Reference laboratories, food producers and those involved in the food supply
 industry.  The FoodSENSE project results are also of importance to policy
 makers and consumer organisations interested in the areas of public health and
 food safety.
 
     This press release contains certain forward-looking statements within the
 meaning of the United States Private Securities Litigation Reform Act of 1995,
 which, by their nature, involve risk and uncertainty because they relate to
 events and depend on circumstances that will occur in the future.  There are a
 number of factors that could cause actual results and developments to differ
 materially from those expressed or implied by these forward-looking
 statements.
 
     Notes:
     XenoSense Ltd was formed in October 2000, as a spin-off from Biacore's
 Food Business Unit and develops and manufactures assay kits and reagents for
 the analysis of food contaminants, such as veterinary medicine residues,
 toxins and bacteria, using Biacore's SPR technology.  Based in Belfast,
 Northern Ireland, the Company received initial funding from Biacore along with
 the University Challenge Fund, which is owned by Queens University, the
 University of Ulster and other private investors.  XenoSense has the right to
 commercialize products and certain areas of research carried out by the
 Department of Agriculture and Rural Development (DARD) in Northern Ireland.
     Biacore is a global market leader in Surface Plasmon Resonance (SPR) based
 technology with its own sales operations in the U.S., across Europe, in Japan,
 Australia and New Zealand.  The technology is protected by a strong patent
 portfolio.  Target groups consist primarily of medical and life science
 research laboratories and pharmaceutical and biotechnology companies all over
 the world.  Biacore focuses on drug discovery as the prime area for future
 growth.  The company currently has six systems on the market with its
 BIACORE(R)3000 system offering specific application in drug discovery
 processes upstream of high-throughput screening (HTS).  A new high-performance
 is currently under late-stage development and will focus on applications
 downstream of HTS.
     Based in Uppsala, Sweden, the company is listed on the OM Stockholm
 Exchange and Nasdaq in the U.S.  In 1999 the company has sales of SEK
 340.4 million and an operating income of SEK 67.6 million.
 
     Further information on Biacore can be found on the web: www.biacore.com .
 
     Address and phone:  Biacore International AB
                         Rapsgatan 7, SE-754 50 Uppsala, SWEDEN
                         Phone: +46 (0)18-675700
                         Fax: +46 (0)18-150111info@biacore.com
 
     More information on the FoodSENSE project can be found at
 http://www.slv.se/foodsense .
 
 SOURCE  Biacore International AB